Comparison of the two most commonly used treatments for pyoderma gangrenosum : results of the STOP GAP randomised controlled trial

Ormerod, Anthony D.Thomas, Kim S.Craig, Fiona E.Mitchell, EleanorGreenlaw, NicolaNorrie, JohnMason, James M.Walton, ShernazJohnston, Graham A.Williams, Hywel C.UK Dermatology Clinical Trials Network's STOP GAP Team2015-10-272015-10-272015-06-12Ormerod, A D, Thomas, K S, Craig, F E, Mitchell, E, Greenlaw, N, Norrie, J, Mason, J M, Walton, S, Johnston, G A, Williams, H C & UK Dermatology Clinical Trials Network's STOP GAP Team 2015, 'Comparison of the two most commonly used treatments for pyoderma gangrenosum : results of the STOP GAP randomised controlled trial', BMJ, vol. 350, 2958. https://doi.org/10.1136/bmj.h29581756-1833http://hdl.handle.net/2164/5115Funding: This publication presents independent research funded by the National Institute for Health Research (NIHR) under its programme grants for applied research (RP-PG-0407-10177).8520738enginflammatory-bowel-diseaseUnited-KingdomcyclosporinetherapymulticentermanagementdiagnosisupdateindexR MedicineNational Institute for Health Research (NIHR)RComparison of the two most commonly used treatments for pyoderma gangrenosum : results of the STOP GAP randomised controlled trialJournal article10.1136/bmj.h2958350